Synopsis
Synopsis
0
CEP/COS
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 2-hydroxy-n,n,n-trimethylethanaminium
2. Bitartrate, Choline
3. Bursine
4. Chloride, Choline
5. Choline Bitartrate
6. Choline Chloride
7. Choline Citrate
8. Choline Hydroxide
9. Choline O Sulfate
10. Choline O-sulfate
11. Citrate, Choline
12. Fagine
13. Hydroxide, Choline
14. O-sulfate, Choline
15. Vidine
1. Choline Ion
2. Bilineurine
3. 62-49-7
4. Choline Cation
5. 2-hydroxy-n,n,n-trimethylethanaminium
6. Cholinum
7. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-
8. (2-hydroxyethyl)trimethylammonium
9. Trimethylethanolamine
10. N-trimethylethanolamine
11. Vitamin J
12. 2-hydroxyethyl(trimethyl)azanium
13. Ccris 5847
14. Ai3-24208
15. Brn 1736748
16. N,n,n-trimethylethanol-ammonium
17. Chebi:15354
18. (beta-hydroxyethyl)trimethylammonium
19. Chembl920
20. N91bdp6h0x
21. (2-hydroxyethyl)trimethylazanium
22. 2-hydroxy-n,n,n-trimethyl-ethanaminium
23. Bilineurine; Choline Cation; Choline Ion; Nanoveson C; Vitamin J
24. Cht
25. Nsc402838
26. Ncgc00015219-03
27. Einecs 200-535-1
28. Unii-n91bdp6h0x
29. 2-hydroxyethyl(trimethyl)ammonium
30. 1oba
31. 2reg
32. 3ppq
33. Choline (dcf)
34. Choline (8ci)
35. Nanoveson C
36. Spectrum_000258
37. 2ha3
38. 3r6u
39. Choline [vandf]
40. Choline [mi]
41. Spectrum2_001938
42. Spectrum4_000867
43. Spectrum5_001579
44. Lopac-c-1754
45. Choline [who-dd]
46. Bmse000285
47. Bmse000953
48. Bmse001003
49. Epitope Id:116046
50. Schembl3142
51. Lopac0_000180
52. Kbiogr_001533
53. Kbioss_000738
54. 3-04-00-00651 (beilstein Handbook Reference)
55. Divk1c_000107
56. N,n,n-trimethylethanolammonium
57. Spbio_001975
58. Gtpl4551
59. Dtxsid8043789
60. Kbio1_000107
61. Kbio2_000738
62. Kbio2_003306
63. Kbio2_005874
64. Nsc6393
65. Ninds_000107
66. (2-hydroxyethyl)trimethyl Ammonium
67. Mono-2-hydroxyethyltrimethylammonium
68. Nsc-6393
69. Zinc3079337
70. Bbl005532
71. Bdbm50026220
72. Stl137772
73. Akos005721137
74. 2-hydroxyethyl)trimethylammonium
75. Ccg-204275
76. Db00122
77. Idi1_000107
78. Ncgc00015219-01
79. Ncgc00015219-02
80. Ncgc00015219-04
81. Ncgc00015219-07
82. Ncgc00015219-10
83. Ncgc00162082-01
84. Carbachol Impurity A [ep Impurity]
85. Sbi-0050168.p003
86. 2-hydroxy-n,n,n-trimethylammonium Chloride
87. (.beta.-hydroxyethyl)trimethylammonium
88. C00114
89. D07690
90. Ab00053822_02
91. Ethanaminium, 2-hydroxy-n,n,n-trimethyl- (9ci)
92. Q193166
93. Acetylcholine Chloride Impurity A [ep Impurity]
| Molecular Weight | 104.17 g/mol |
|---|---|
| Molecular Formula | C5H14NO+ |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 104.107539070 g/mol |
| Monoisotopic Mass | 104.107539070 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 1 |
| Complexity | 46.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For nutritional supplementation, also for treating dietary shortage or imbalance
This compound is needed for good nerve conduction throughout the CNS (central nervous system) as it is a precursor to acetylcholine (ACh). Choline is also needed for gallbladder regulation, liver function and lecithin (a key lipid) formation. Choline also aids in fat and cholesterol metabolism and prevents excessive fat build up in the liver. Choline has been used to mitigate the effects of Parkinsonism and tardive dyskinesia. Choline deficiencies may result in excessive build-up of fat in the liver, high blood pressure, gastric ulcers, kidney and liver dysfunction and stunted growth.
Lipotropic Agents
Endogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues. (See all compounds classified as Lipotropic Agents.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
Choline has known human metabolites that include Trimethylazanium and acetaldehyde.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Choline is a major part of the polar head group of phosphatidylcholine. Phosphatidylcholine's role in the maintenance of cell membrane integrity is vital to all of the basic biological processes: information flow, intracellular communication and bioenergetics. Inadequate choline intake would negatively affect all these processes. Choline is also a major part of another membrane phospholipid, sphingomyelin, also important for the maintenance of cell structure and function. It is noteworthy and not surprising that choline deficiency in cell culture causes apoptosis or programmed cell death. This appears to be due to abnormalities in cell membrane phosphatidylcholine content and an increase in ceramide, a precursor, as well as a metabolite, of sphingomyelin. Ceramide accumulation, which is caused by choline deficiency, appears to activate Caspase, a type of enzyme that mediates apoptosis. Betaine or trimethylglycine is derived from choline via an oxidation reaction. Betaine is one of the factors that maintains low levels of homocysteine by resynthesizing L-methionine from homocysteine. Elevated homocysteine levels are a significant risk factor for atherosclerosis, as well as other cardiovascular and neurological disorders. Acetylcholine is one of the major neurotransmitters and requires choline for its synthesis. Adequate acetylcholine levels in the brain are believed to be protective against certain types of dementia, including Alzheimer's disease.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4013
Submission : 1980-12-15
Status : Inactive
Type : II




Registration Number : 229MF10002
Registrant's Address : Nattermannallee 1, D-50829 Cologne, Germany
Initial Date of Registration : 2017-01-10
Latest Date of Registration :

Registrant Name : Toru Co., Ltd.
Registration Date : 2023-07-28
Registration Number : 20230313-211-J-1459(2)
Manufacturer Name : Bajaj Healthcare Limited (Unit-2)
Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara - 391 776, India

Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2023-07-25
Registration Number : 20230313-211-J-1459(1)
Manufacturer Name : Bajaj Healthcare Limited (Unit-2)
Manufacturer Address : Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara - 391 776, India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 13, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Details : TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 13, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925, a first-in-class topical Bruton’s tyrosine kinase (BTK) inhibitor, it is being investigated for the treament of individuals with moderate to severe dry eye disease (DED).
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 07, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Telios Announces Successful Phase 2 Results for TL-925, a Treatment for Dry Eye Disease
Details : TL-925, a first-in-class topical Bruton’s tyrosine kinase (BTK) inhibitor, it is being investigated for the treament of individuals with moderate to severe dry eye disease (DED).
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 07, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 05, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Of TL-925 For The Treatment of AC
Details : TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 05, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 26, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
Details : TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 26, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 01, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of TL-925 for the Treatment of Allergic Conjunctivitis
Details : TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Conjunctivitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 01, 2023

Details:
Choline is a Dietary Supplement drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alzheimer Disease.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Dietary Supplement
Sponsor: MD Anderson Cancer Center | Massachusetts Institute of Technology | BALCHEM
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 30, 2023

Choline Effects - Pre-symptomatic AD
Details : Choline is a Dietary Supplement drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 30, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Lead Product(s): Choline,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 27, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of TL-925 as a Treatment for Dry Eye Disease
Details : TL-925 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 27, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
WHITNEY JOHNS ACTIVE (lepidium meyenii root extract) proven all-natural BPF Gold Citrus Bergamot SuperFruit™ formulation, has been clinically proven to increase NO by 73% and oxygen consumption by 24%, thereby enhancing physical performance and the benefits of exercise.
Lead Product(s): Lepidium Meyenii Root Extract,Choline,Magnesium
Therapeutic Area: Musculoskeletal Brand Name: Active
Study Phase: Approved FDFProduct Type: Plant Extract/Herbal
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 22, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lepidium Meyenii Root Extract,Choline,Magnesium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Healthy Extracts’ WHITNEY JOHNS ACTIVE™ Clinically Proven to Enhance Physical Performance by I...
Details : WHITNEY JOHNS ACTIVE (lepidium meyenii root extract) proven all-natural BPF Gold Citrus Bergamot SuperFruit™ formulation, has been clinically proven to increase NO by 73% and oxygen consumption by 24%, thereby enhancing physical performance and the ben...
Product Name : Active
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 22, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Phosphatidylcholine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Depressive Disorder, Major.
Lead Product(s): Choline,Phosphatidylethanolamine,Phosphatidylserine,Citalopram
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 23, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Choline,Phosphatidylethanolamine,Phosphatidylserine,Citalopram
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
Details : Phosphatidylcholine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Depressive Disorder, Major.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 23, 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : OXTRIPHYLLINE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 200MG
Approval Date : 1983-08-25
Application Number : 87835
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : OXTRIPHYLLINE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Approval Date : 1983-08-25
Application Number : 87866
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AP
Brand Name : CHOLINE C-11
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 4-33.1mCi/ML
Approval Date : 2012-09-12
Application Number : 203155
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : OXTRIPHYLLINE PEDIATRIC
Dosage Form : SYRUP;ORAL
Dosage Strength : 50MG/5ML
Approval Date : 1983-12-05
Application Number : 88242
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : OXTRIPHYLLINE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 100MG/5ML
Approval Date : 1983-12-05
Application Number : 88243
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CHOLEDYL
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Approval Date : 1982-01-01
Application Number : 9268
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CHOLEDYL
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 200MG
Approval Date : 1982-01-01
Application Number : 9268
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CHOLEDYL
Dosage Form : SYRUP;ORAL
Dosage Strength : 50MG/5ML
Approval Date : 1982-01-01
Application Number : 9268
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CHOLINE C-11
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 4-100mCi/ML
Approval Date : 2015-10-29
Application Number : 205690
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CHOLEDYL SA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 400MG
Approval Date : 1983-05-24
Application Number : 87863
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Ukraine
Brand Name : Product Under Development
Dosage Form : Capsule
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Mundisal
Dosage Form : Gel
Dosage Strength : 87.1mg/g
Packaging :
Approval Date : 01/06/1967
Application Number : 33332
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Teovent
Dosage Form : Rectal Solution
Dosage Strength : 100mg
Packaging :
Approval Date : 06/02/1981
Application Number : 19810206000081
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Teovent
Dosage Form : Tablet
Dosage Strength : 135mg
Packaging :
Approval Date : 15/12/1978
Application Number : 19781215000082
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Teovent
Dosage Form : Rectal Solution
Dosage Strength : 250mg
Packaging :
Approval Date : 18/12/1981
Application Number : 19811218000076
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Teovent
Dosage Form : Rectal Solution
Dosage Strength : 50mg
Packaging :
Approval Date : 06/02/1981
Application Number : 19810206000074
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Teovent
Dosage Form : Oral Solution
Dosage Strength : 6.5mg/ml
Packaging :
Approval Date : 15/12/1978
Application Number : 19781215000099
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Choline Salicylates; Cetalkonium Chloride; Levomenol
Brand Name : Tenderdol
Dosage Form : Gel
Dosage Strength :
Packaging :
Approval Date : 21/09/1990
Application Number : 49153
Regulatory Info : Allowed
Registration Country : Switzerland

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Mongolia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Brand Name : BIOLYSIN
Dosage Form : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Packaging : SMART 100 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Mongolia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : SMART 100 ML
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Dosage : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Mongolia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Nigeria
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Brand Name : BIOLYSIN
Dosage Form : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Packaging : EMULSION 250 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Nigeria

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : EMULSION 250 ML
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Dosage : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Nigeria

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Indonesia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Brand Name : BIOLYSIN
Dosage Form : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Packaging : EMULSION 250 ML (WINKAR EMULSION)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Indonesia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : EMULSION 250 ML (WINKAR EMULSION)
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Dosage : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Indonesia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Cambodia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Arachidonic Acid; Docosahexaenoic Acids; Choline
Brand Name : BIOLYSIN
Dosage Form : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Packaging : SMART SYRUP 100 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : SMART SYRUP 100 ML
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Arachidonic Acid; Docosahexaenoic Acids; Choline
Dosage : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Cambodia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Brand Name : BIOLYSIN
Dosage Form : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Packaging : EMULSION 250 ML (WINKAR EMULSION)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : EMULSION 250 ML (WINKAR EMULSION)
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin D3; Docosahexaenoic Acids; Arachidonic Acid; Choline; Fish Oil; Magnesium Gluconate API; Calcium Lactate Gluconate
Dosage : Emulsion Solution
Dosage Strength : 1000IU; 0.6MG; 0.6MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Cambodia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Brand Name : BIOLYSIN
Dosage Form : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Packaging : SMART STRAWBERRY SYRUP 100 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : SMART STRAWBERRY SYRUP 100 ML
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Dosage : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Cambodia
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Brand Name : BIOLYSIN
Dosage Form : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Packaging : SMART STRAWBERRY SYRUP 60 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : SMART STRAWBERRY SYRUP 60 ML
Regulatory Info :
Vitamin A; Thiamine; Riboflavin; Pyridoxine Hydrochloride; Vitamin B12; Vitamin D3; Lysine Hydrochloride; Docosahexaenoic Acids; Arachidonic Acid; Choline
Dosage : Syrup
Dosage Strength : 1000IU; 1.5MG; 1.5MG; ...
Brand Name : BIOLYSIN
Approval Date :
Application Number :
Registration Country : Cambodia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Ukraine
Hexetidine; Choline Salicylate; Chlorobutanol Hemihydrate
Brand Name : Sangiva
Dosage Form : Spray
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Hexetidine; Choline Salicylate; Chlorobutanol Hemihydrate
Dosage : Spray
Dosage Strength :
Brand Name : Sangiva
Approval Date :
Application Number :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country :
Choline; Levocarnitine; Betaine; Silybum marianum L.; Dl-Methionine
Brand Name : Liver Protector Plus
Dosage Form :
Dosage Strength :
Packaging : 200 ML & 1 Litre Bottle, 5 Litre Jug
Approval Date :
Application Number :
Regulatory Info :
Registration Country :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 200 ML & 1 Litre Bottle, 5 Litre Jug
Regulatory Info :
Choline; Levocarnitine; Betaine; Silybum marianum L.; Dl-Methionine
Dosage :
Dosage Strength :
Brand Name : Liver Protector Plus
Approval Date :
Application Number :
Registration Country :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country :
Thiamine; Riboflavin; Vitamin B 12; Vitamin- B12; Ascorbic Acid; Vitamin D3; Vitamin E; Vitamin K 3; Nicotinamide; Dexpanthenol; Choline; Folic Acid; Biotin
Brand Name : Aminovit Oral
Dosage Form :
Dosage Strength :
Packaging : 200 ML & 1 Litre Bottle, 5 Litre Jug
Approval Date :
Application Number :
Regulatory Info :
Registration Country :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 200 ML & 1 Litre Bottle, 5 Litre Jug
Regulatory Info :
Thiamine; Riboflavin; Vitamin B 12; Vitamin- B12; Ascorbic Acid; Vitamin D3; Vitamin E; Vitamin K 3; Nicotinamide; Dexpanthenol; Choline; Folic Acid; Biotin
Dosage :
Dosage Strength :
Brand Name : Aminovit Oral
Approval Date :
Application Number :
Registration Country :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Choline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Choline manufacturer or Choline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Choline manufacturer or Choline supplier.
PharmaCompass also assists you with knowing the Choline API Price utilized in the formulation of products. Choline API Price is not always fixed or binding as the Choline Price is obtained through a variety of data sources. The Choline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Choline C-11 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Choline C-11, including repackagers and relabelers. The FDA regulates Choline C-11 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Choline C-11 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Choline C-11 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Choline C-11 supplier is an individual or a company that provides Choline C-11 active pharmaceutical ingredient (API) or Choline C-11 finished formulations upon request. The Choline C-11 suppliers may include Choline C-11 API manufacturers, exporters, distributors and traders.
click here to find a list of Choline C-11 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Choline C-11 DMF (Drug Master File) is a document detailing the whole manufacturing process of Choline C-11 active pharmaceutical ingredient (API) in detail. Different forms of Choline C-11 DMFs exist exist since differing nations have different regulations, such as Choline C-11 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Choline C-11 DMF submitted to regulatory agencies in the US is known as a USDMF. Choline C-11 USDMF includes data on Choline C-11's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Choline C-11 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Choline C-11 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Choline C-11 Drug Master File in Japan (Choline C-11 JDMF) empowers Choline C-11 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Choline C-11 JDMF during the approval evaluation for pharmaceutical products. At the time of Choline C-11 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Choline C-11 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Choline C-11 Drug Master File in Korea (Choline C-11 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Choline C-11. The MFDS reviews the Choline C-11 KDMF as part of the drug registration process and uses the information provided in the Choline C-11 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Choline C-11 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Choline C-11 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Choline C-11 suppliers with KDMF on PharmaCompass.
A Choline C-11 written confirmation (Choline C-11 WC) is an official document issued by a regulatory agency to a Choline C-11 manufacturer, verifying that the manufacturing facility of a Choline C-11 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Choline C-11 APIs or Choline C-11 finished pharmaceutical products to another nation, regulatory agencies frequently require a Choline C-11 WC (written confirmation) as part of the regulatory process.
click here to find a list of Choline C-11 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Choline C-11 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Choline C-11 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Choline C-11 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Choline C-11 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Choline C-11 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Choline C-11 suppliers with NDC on PharmaCompass.
Choline C-11 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Choline C-11 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Choline C-11 GMP manufacturer or Choline C-11 GMP API supplier for your needs.
A Choline C-11 CoA (Certificate of Analysis) is a formal document that attests to Choline C-11's compliance with Choline C-11 specifications and serves as a tool for batch-level quality control.
Choline C-11 CoA mostly includes findings from lab analyses of a specific batch. For each Choline C-11 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Choline C-11 may be tested according to a variety of international standards, such as European Pharmacopoeia (Choline C-11 EP), Choline C-11 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Choline C-11 USP).